Bridgebio Pharma Inc. buy me8
Start price
06.03.23
/
0%
€15.95
Target price
06.03.24
€25.00
Performance (%)
72.37%
End price
07.03.24
€27.49
Summary
This prediction ended on 07.03.24 with a price of €27.49. With a performance of 72.37% the BUY prediction by me8 was a big success. This prediction was marked as speculative and is excluded from me8's performance statistics.Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Bridgebio Pharma Inc. | - | - | - |
iShares Core DAX® | 1.663% | 6.945% | 18.807% |
iShares Nasdaq 100 | 1.261% | 4.883% | 23.667% |
iShares Nikkei 225® | 0.654% | 10.007% | 15.047% |
iShares S&P 500 | 1.403% | 4.350% | 23.305% |
According to me8 what are the pros and cons of Bridgebio Pharma Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Good culture
Capable Management
Cons
No uniques
Comments by me8 for this prediction
In the thread Bridgebio Pharma Inc. diskutieren
Buy Bridgebio Pharma Inc.
Kursziel gesetzt auf 25,0
In the thread Trading Bridgebio Pharma Inc.
Die von me8 gewählte maximale Laufzeit wurde überschritten
Stopped prediction by me8 for Bridgebio Pharma Inc.
Bridgebio Pharma Inc.
Start price
Target price
Perf. (%)
€12.20
27.12.21
27.12.21
€15.00
27.12.22
27.12.22
5.74%
08.01.22
08.01.22
Could be worthwhile Investment >10% per year
Good culture
Capable Management
No uniques